How Much Upside is Left in Aurinia (AUPH)? Wall Street Analysts Think 96.51%

Aurinia Pharmaceuticals (AUPH) closed the last trading session at $5.16, gaining 3.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $10.14 indicates a 96.5% upside potential.The mean estimate comprises seven short-term price targets with a standard deviation of $3.13. While the lowest estimate of $6 indicates a 16.3% increase from the current price level, the most optimistic anal ...